Haleon logo

Haleon Stock

StockStock
ISIN: GB00BMX86B70
Ticker: HLN
GB00BMX86B70
HLN

Price

Historical dividends and forecast

All dividend data

Haleon has so far distributed $0.0798 in 2024. The next dividend will be paid on 16.05.2025


$0.0702

CHART BY

Frequently asked questions

What is Haleon's market capitalization?

The market capitalization of Haleon is $41.93B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Haleon's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Haleon is 17.27. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Haleon?

Haleon's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.268. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Haleon's stock?

Currently, 18 analysts cover Haleon's stock, with a consensus target price of $4.694. Analyst ratings provide insights into the stock's expected performance.

What is Haleon's revenue over the trailing twelve months?

Over the trailing twelve months, Haleon reported a revenue of $14.31B.

What is the EBITDA for Haleon?

Haleon's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.47B. EBITDA measures the company's overall financial performance.

How many employees does Haleon have, and what sector and industry does it belong to?

Haleon employs approximately 24,000 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Haleon's shares?

The free float of Haleon is 8.08B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$41.93B

EPS (TTM)

 
$0.268

Free Float

 
8.08B

P/E ratio (TTM)

 
17.27

Revenue (TTM)

 
$14.31B

EBITDA (TTM)

 
$3.47B

Pricing

1D span
$4.601$4.705
52W span
$3.923$5.337

Analyst Ratings

The price target is $4.694 and the stock is covered by 18 analysts.

Buy

12

Hold

4

Sell

2

Information

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

24,000

Biotechnology & Drugs

Health Care

Identifier

ISIN

GB00BMX86B70

Primary Ticker

HLN

Knockouts

Join the conversation